• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » Acquisitions roundup: BAE throws down $86 million for Fairchild Imaging

Acquisitions roundup: BAE throws down $86 million for Fairchild Imaging

January 24, 2011 By MassDevice staff

M and A Roundup

Here’s a roundup of companies announcing mergers and acquisitions:

  • BAE throws down $86 million for Fairchild Imaging
    BAE Systems plc (OTC:BAESY) entered into a definitive agreement to acquire Fairchild Imaging Inc., a privately held company specializing in solid-state electronic imaging components, cameras, and systems for aerospace, industrial, medical, and scientific imaging applications. BAE Systems currently owns 8.7 percent of the equity of Fairchild Imaging and, upon completion of the acquisition for a cash consideration of approximately $86 million, will have acquired all of the remaining outstanding equity. The proposed acquisition of Fairchild Imaging reflects BAE Systems’ strategy to grow its electronic systems business and will complement existing electro-imaging capabilities, technologies and product offerings, according to the company.
    Read more
  • IDEX buys out Advanced Thin Films
    IDEX Corp. (NYSE:IEX) entered into a definitive agreement to purchase Advanced Thin Films LLC. ATFilms, with approximately $9 million in revenue, specializes in optical components and coatings for applications in the fields of scientific research, defense, aerospace, telecommunications and electronics manufacturing. ATFilms’ core competence is in the design and manufacture of filters, splitters, reflectors and mirrors with the precise physical properties required to support their customers’ most challenging and cutting-edge optical applications. The Boulder, Col.-based copmany will operate within IDEX’s Health and Science Technologies segment as a part of the IDEX optical products platform. AT Films will be acquired for cash consideration of $32 million and is expected, inclusive of all potential earn-out, to be accretive to earnings in 2011. The acquisition is expected to close by the end of the month pending the discharge of indebtedness of the company.
    Read more
  • inVentiv Health to acquire clinical development outsourcing businesses from Ingenix
    inVentiv Health, a provider of outsourced clinical development, launch and commercial services to the global health care industry, signed a definitive agreement to purchase the i3 clinical development businesses from Ingenix. The proposed transaction, covering businesses that generate approximately $400 million in annual gross revenue, is expected to close in the first half of this year. Upon close of the proposed transaction, inVentiv will acquire the following businesses from Ingenix: i3 Research, i3 Statprobe and i3 Pharma Resourcing. These businesses will retain the i3 brand name and will be aligned with inVentiv’s other clinical development offerings, advancing i3’s position as a global CRO serving pharmaceutical, biotech and medical device companies. Ingenix will align all of its commercialization, safety, regulatory and late phase service offerings under its newly-launched Ingenix Life Sciences division, according to the company.
    Read more
  • NeoStem and Progenitor Cell Therapy close merger deal
    NeoStem Inc. (NYSE:NBS) and Progenitor Cell Therapy LLC closed of their previously announced merger transaction. NeoStem is an international biopharmaceutical company with a 51 percent ownership interest in a Chinese generic pharmaceutical manufacturing company and has stem cell operations in the U.S. and China, while Progenitor Cell Therapy is a privately held cell therapy company with operations on the east and west coast of the U.S. serving the cell therapy community with cGMP state-of-the art cell therapy manufacturing facilities, and processing and storage facilities for stem cells collected from the umbilical cord at birth.
    Read more
  • Mould Technologies Group acquires Magor Mold
    Mould Technologies Group, which incorporates Diessenhofen, Switzerland-based Schöttli AG, has acquired all shares in San Dimas, Calif.-based Magor Mold Inc. MTG also owns s-mouldtech in Suzhou, China. The three mould engineering specialists have joined forces to provide customers, many of whom are medical device OEMs, with an enhanced portfolio of moulds from a single supplier, according to medtechinsider.
    Read more
  • Report: Healthcare M&A activity for 2010 remained strong
    During 2010 and based on preliminary results, a total of 913 mergers and acquisitions were announced in 13 sectors of the health care industry, a 3 percent decrease from the 945 transactions announced in 2009, according to a report from Irving Levin Associates Inc. Based on prices revealed to date, a total of $206.5 billion was committed to finance the year’s 913 deals. This represents an 11 percent decrease from the $232.2 billion in 2009. In terms of dollars committed to merger and acquisition deals, 2010 is the fifth-largest year of the past 10 years.
    Read more

M&A deal and dollar volume for 2010 and
2009*

DEAL VOLUME DOLLAR VOLUME
Sector 2010 2009 % Change 2010 2009 % Change
Behavioral Health 7 11 -36% $3,491,000,000 $79,659,000 4,280%
Home Health 41 42 -2% 1,405,083,000 140,997,000 896%
Hospitals 75 53 42% 17,442,095,000 1,813,300,000 860%
Laboratories, MRI, Dialysis 39 30 30% 2,230,061,950 90,457,000 2,365%
Long-Term Care 103 88 17% 11,735,704,464 2,918,175,000 302%
Managed Care 13 15 -13% 4,093,323,000 850,000,000 380%
Physician Medical Groups 60 41 46% 425,439,000 99,100,000 329%
Rehabilitation 12 11 9% 236,890,000 22,085,000 973%
Other

91

78

16%

23,014,518,522

6,276,251,881

267%

Services Subtotal 441 369 20% $64,074,114,936 $12,290,024,881 421%
Biotechnology 110 193 -43% $55,951,409,000 $47,445,849,040 18%
E-Health 73 69 6% 6,893,651,063 11,534,925,000 -40%
Medical Devices 165 176 -6% 41,493,789,929 13,820,275,951 200%
Pharmaceuticals

124

138

-10%

38,101,480,000

147,122,047,185

-74%

Technology Subtotal 472 576 -18% $142,440,330,892 $219,923,097,176 -35%
Grand Total 913 945 -3% $206,514,445,828 $232,213,112,057 -11%
*2010 Preliminary Figures

Table compiled by Irving Levin Associates.

Filed Under: Business/Financial News, Mergers & Acquisitions, News Well

In case you missed it

  • Shareholder lawsuit over BD’s Alaris pumps recall moves forward
  • Dyad Medical wins FDA clearance for cardiac imaging platform Echo:Prio
  • Outset Medical wins national VA contract
  • Inspire Medical Systems appoints former Zimmer Biomet exec as VP of investor relations
  • Abbott will spend $450M to up FreeStyle Libre production in Ireland
  • Acutus Medical ticks up on revenue beat, missed EPS in Q2 results
  • ResMed expects steady growth over the next year
  • Ambu is letting go of 200 employees
  • Medtronic has Class I recall for low-shock risk in ICDs
  • Titan Medical to start manufacturing Enos systems later this year
  • ZimVie sales down more than 11% in Q2 as it streamlines after spinoff
  • Cardinal Health’s CFO to move up to corner office
  • Levita Magnetics raises $26M for Magnetic-Assisted Robotic Surgery platform
  • Data supports use of Channel Medsystems Cerene cryotherapy
  • The 10 largest orthopedic device companies in the world
  • Nanopath raises $10M Series A for women’s health diagnostics
  • Avenda wins FDA IDE nod for AI-enabled prostate cancer therapy

RSS From Medical Design & Outsourcing

  • TE Connectivity opens global medical device prototyping center in Ireland
    TE Connectivity (NYSE:TEL) today announced it opened its global Propelus Prototype Center for medical devices in Galway, Ireland. The $5 million rapid prototyping center was built into its existing manufacturing site in Galway and directly connects TE engineers with customers to reduce development time and increase speed to market for lifesaving and life-improving medical devices. Propelus… […]
  • Contract manufacturer Minnetronix Medical launches its first in-house product, MindsEye
    Minnetronix Medical has launched MindsEye, making it the first medical device that the contract developer and manufacturer has conceived and commercialized. St. Paul-based Minnetronix Medical’s MindsEye is the first expandable brain access port on the market. The FDA cleared the device under the 510(k) pathway in August 2020. The minimally invasive device gives neurosurgeons deep… […]
  • What’s next for Jennifer Fried after leaving Explorer Surgical?
    Explorer Surgical co-founder Jennifer Fried has resigned from the company after selling it to Global Healthcare Exchange in October. Fried announced her departure last week on LinkedIn, saying she’s preparing for her next professional chapter. “It’s bittersweet — I’m so proud of everything our team has built and accomplished,” Fried wrote. “The time has flown… […]
  • The 24 best medical device innovations of 2022
    The Galien Foundation recently announced its nominees of medical device innovations for its 2022 Prix Galien USA awards. There are 24 medical technologies nominated for the annual award this year, up from 18 nominees in 2021. The Galien Foundation’s annual Prix Galien awards highlight devices, biotechnology and pharmaceutical products designed to improve the human condition.… […]
  • FDA issues new COVID-19 testing guidance to avoid false negatives
    COVID-19 testing should be repeated following a negative result on any antigen test, the FDA said in a move that could increase demand for diagnostics manufacturers. The latest guidance from the federal health agency is for negative COVID-19 antigen test results regardless of the presence or absence of symptoms. The federal agency said recent studies… […]
  • Confluent Medical expands Costa Rica manufacturing footprint for nitinol, complex catheter production
    Confluent Medical Technologies this week announced the opening of its new addition to its Costa Rica manufacturing facility. The expansion adds 66,000 sq. ft to its large-scale manufacturing center of excellence in Alajuela, Costa Rica to expand Confluent’s capacity for nitinol component processing and complex catheter manufacturing. “Confluent has experienced consistent and strong growth in… […]
  • FDA’s breakthrough medical device designations tally nears 700
    Stewart Eisenhart, Emergo Group The US Food and Drug Administration has granted almost 700 designations over the past seven years under a voluntary program for expedited regulatory review of medical devices and combination products that facilitate more effective treatment or diagnosis of serious diseases. According to recent metrics published by FDA, the agency has issued a total of… […]
  • Lifecore Biomedical’s owner plans to go all-in on contract development and manufacturing
    Lifecore Biomedical parent company Landec Corp. (Nasdaq:LNDC) plans to take the subsidiary’s name, leadership and headquarters as its own and sell off food businesses to focus on contract development and manufacturing. Santa Maria, California-based Landec said it will rename itself as Lifecore Biomedical “in the near future” and change its Nasdaq ticker to LFCR. Landec… […]
  • COVID-19 immunity test developers at MIT seek diagnostic manufacturer
    MIT researchers have developed a device for predicting an individual’s COVID-19 immunity and are looking for a diagnostic company to get it manufactured in large numbers and approved by the FDA. The lateral flow test uses the same technology as at-home rapid antigen COVID-19 tests to measure neutralizing antibodies for SARS-CoV-2 in a blood sample,… […]
  • GE Healthcare picks AI imaging startups for inaugural Edison Accelerator
    GE Healthcare and Nex Cubed have selected seven companies focused on artificial-intelligence-augmented medical imaging for the first cohort of the Edison Accelerator in Canada. The companies will be matched with mentors and test their technologies with GE’s new Edison Digital Health Platform over the next three months. The program will end with innovation showcase presentations… […]
  • Boston Scientific whistleblower launches corruption investigation
    Boston Scientific (NYSE:BSX) is investigating claims that the company violated the U.S. Foreign Corrupt Practices Act in Vietnam. Marlborough, Massachusetts–based Boston Scientific disclosed receipt of a whistleblower’s allegations in its latest filing with the Securities and Exchange Commission. “In March 2022, the company received a whistleblower letter alleging Foreign Corrupt Practices Act violations in Vietnam.… […]

Leave a Reply

You must be logged in to post a comment.

Primary Sidebar

DeviceTalks Weekly

August 12, 2022
DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy